Mirror-Image Antimicrobial Peptides Work Just as Well Against Bacteria

D-amino acid versions of naturally occurring antimicrobial peptides (cecropin A, magainin 2, melittin) retain full antibacterial activity, proving they kill bacteria through membrane disruption rather than receptor binding.

RPEP-00176In VitroModerate Evidence1990RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
in-vitro
Evidence
Moderate Evidence
Sample
Not reported

What This Study Found

D-enantiomers of cecropin A, magainin 2, and melittin retained equivalent antibacterial and channel-forming activity, confirming a non-receptor-mediated membrane disruption mechanism.

Key Numbers

How They Did This

Researchers chemically synthesized D-enantiomers of five antimicrobial peptides, verified their mirror-image structure via circular dichroism, and tested antibacterial activity and membrane channel formation in vitro.

Why This Research Matters

This finding opened the door to developing D-amino acid antimicrobial peptides that would resist enzymatic degradation in the body, potentially creating longer-lasting antibiotic treatments.

The Bigger Picture

D-amino acid peptides resist proteases (enzymes that break down proteins), making them potentially more stable as drugs. This study showed antimicrobial peptides can be made in D-form without losing effectiveness.

What This Study Doesn't Tell Us

In vitro study only. The practical pharmacological advantages of D-amino acid antimicrobial peptides (stability, bioavailability) were not tested in living organisms.

Questions This Raises

  • ?Do D-amino acid antimicrobial peptides show improved stability and half-life in vivo?
  • ?Could D-form peptides reduce the development of bacterial resistance?

Trust & Context

Key Stat:
Equal activity in mirror form D-enantiomers matched L-form antibacterial potency, proving membrane disruption mechanism
Evidence Grade:
Moderate in vitro evidence with well-controlled enantiomer comparisons, but no in vivo testing.
Study Age:
Published in 1990, this is a landmark study in antimicrobial peptide design that influenced decades of subsequent research.
Original Title:
All-D amino acid-containing channel-forming antibiotic peptides.
Published In:
Proceedings of the National Academy of Sciences of the United States of America, 87(12), 4761-5 (1990)
Database ID:
RPEP-00176

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Frequently Asked Questions

What are D-amino acids?

Amino acids come in two mirror-image forms: L (left-handed) and D (right-handed). Nearly all biological proteins use L-amino acids. D-amino acid peptides are mirror images that resist breakdown by the body's enzymes, potentially lasting longer as drugs.

Why does this matter for fighting antibiotic resistance?

Antimicrobial peptides that work by physically disrupting bacterial membranes are harder for bacteria to develop resistance against compared to traditional antibiotics that target specific proteins. Making them in D-form adds enzymatic stability.

Read More on RethinkPeptides

Cite This Study

RPEP-00176·https://rethinkpeptides.com/research/RPEP-00176

APA

Wade, D; Boman, A; Wåhlin, B; Drain, C M; Andreu, D; Boman, H G; Merrifield, R B. (1990). All-D amino acid-containing channel-forming antibiotic peptides.. Proceedings of the National Academy of Sciences of the United States of America, 87(12), 4761-5.

MLA

Wade, D, et al. "All-D amino acid-containing channel-forming antibiotic peptides.." Proceedings of the National Academy of Sciences of the United States of America, 1990.

RethinkPeptides

RethinkPeptides Research Database. "All-D amino acid-containing channel-forming antibiotic pepti..." RPEP-00176. Retrieved from https://rethinkpeptides.com/research/wade-1990-alld-amino-acidcontaining-channelforming

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.